116 related articles for article (PubMed ID: 3124302)
1. Pulmonary vascular responses induced by the pyrrolizidine alkaloid, monocrotaline, in rats.
Shubat PJ; Banner W; Huxtable RJ
Toxicon; 1987; 25(9):995-1002. PubMed ID: 3124302
[TBL] [Abstract][Full Text] [Related]
2. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
Altiere RJ; Olson JW; Gillespie MN
J Pharmacol Exp Ther; 1986 Feb; 236(2):390-5. PubMed ID: 3080584
[TBL] [Abstract][Full Text] [Related]
3. Endothelin and 5-hydroxytryptamine on rat pulmonary artery in pulmonary hypertension.
Wanstall JC; O'Donnell SR
Eur J Pharmacol; 1990 Feb; 176(2):159-68. PubMed ID: 2107090
[TBL] [Abstract][Full Text] [Related]
4. Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats.
Gillespie MN; Olson JW; Reinsel CN; O'Connor WN; Altiere RJ
Am J Physiol; 1986 Jul; 251(1 Pt 2):H109-14. PubMed ID: 2942040
[TBL] [Abstract][Full Text] [Related]
5. Increased vascular responsiveness in lungs of rats with pulmonary hypertension induced by monocrotaline pyrrole.
Hilliker KS; Roth RA
Am Rev Respir Dis; 1985 Jan; 131(1):46-50. PubMed ID: 3966714
[TBL] [Abstract][Full Text] [Related]
6. Ca2(+)-induced contraction and hyperreactivity of pulmonary arterial smooth muscle in monocrotaline-treated rats.
Takenaka T; Ogawa Y; Tobise K
Jpn Circ J; 1990 May; 54(5):515-23. PubMed ID: 2122039
[TBL] [Abstract][Full Text] [Related]
7. Altered artery mechanics and structure in monocrotaline pulmonary hypertension.
Langleben D; Szarek JL; Coflesky JT; Jones RC; Reid LM; Evans JN
J Appl Physiol (1985); 1988 Nov; 65(5):2326-31. PubMed ID: 3145283
[TBL] [Abstract][Full Text] [Related]
8. Na+/K(+)-adenosine triphosphatase activity of pulmonary arteries after intoxication with the pyrrolizidine alkaloid, monocrotaline.
Shubat PJ; Bowers RJ; Huxtable RJ
J Pharmacol Exp Ther; 1990 Jan; 252(1):70-6. PubMed ID: 2153811
[TBL] [Abstract][Full Text] [Related]
9. Potassium dependent relaxation of isolated pulmonary artery segments following ingestion of monocrotaline.
Shubat PJ; Huxtable RJ
Proc West Pharmacol Soc; 1988; 31():313-5. PubMed ID: 3145503
[No Abstract] [Full Text] [Related]
10. Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline.
Shubat PJ; Hubbard AK; Huxtable RJ
J Toxicol Environ Health; 1989; 28(4):445-60. PubMed ID: 2531804
[TBL] [Abstract][Full Text] [Related]
11. alpha-Difluoromethylornithine, an inhibitor of polyamine synthesis, attenuates monocrotaline-induced pulmonary vascular hyperresponsiveness in isolated perfused rat lungs.
Gillespie MN; Dyer KK; Olson JW; O'Connor WN; Altiere RJ
Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):365-78. PubMed ID: 3936139
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole.
Ganey PE; Roth RA
Toxicol Appl Pharmacol; 1987 Apr; 88(2):157-64. PubMed ID: 3564035
[TBL] [Abstract][Full Text] [Related]
13. Attenuated noradrenaline-induced contraction of pulmonary arteries from rats treated with monocrotaline: role of rho kinase.
Khan I; Oriowo MA; Chandrasekhar B; Kadavil EA
J Vasc Res; 2005; 42(5):433-40. PubMed ID: 16127279
[TBL] [Abstract][Full Text] [Related]
14. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension.
Rosenberg HC; Rabinovitch M
Am J Physiol; 1988 Dec; 255(6 Pt 2):H1484-91. PubMed ID: 3144186
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
Kay JM; Keane PM; Suyama KL; Gauthier D
Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs.
Archer SL; Rist K; Nelson DP; DeMaster EG; Cowan N; Weir EK
J Appl Physiol (1985); 1990 Feb; 68(2):735-47. PubMed ID: 2156794
[TBL] [Abstract][Full Text] [Related]
17. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
Reindel JF; Ganey PE; Wagner JG; Slocombe RF; Roth RA
Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110
[TBL] [Abstract][Full Text] [Related]
18. Polyamine synthesis blockade in monocrotaline-induced pneumotoxicity.
Olson JW; Orlinska U; Gillespie MN
Biochem Pharmacol; 1989 Sep; 38(17):2903-10. PubMed ID: 2505777
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension induced in rats by monocrotaline and chronic hypoxia is reduced by p-chlorophenylalanine.
Kay JM; Keane PM; Suyama KL
Respiration; 1985; 47(1):48-56. PubMed ID: 3156395
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary capillary density in rats given monocrotaline. A cast corrosion study.
Schraufnagel DE; Schmid A
Am Rev Respir Dis; 1989 Nov; 140(5):1405-9. PubMed ID: 2510567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
